(Tromsø 20. December 2018) Biotec Pharmacon’s (OSE: Biotec) subsidiary ArcticZymes and Vectron Biosolutions AS (Vectron) have signed a non-exclusive license agreement for recombinant manufacturing of enzymes. ArcticZymes is a leader in the development and commercialization of novel enzymes applied to molecular biology kits, In Vitro Diagnostics (IVD), gene therapy, and protein purification. Vectron supplies the life science industry with superior …
ArcticZymes signs new supply agreement for enzyme, Cod UNG
(Tromsø 13. December 2018) Biotec Pharmacon’s (OSE: Biotec) subsidiary ArcticZymes has signed a supply agreement with a major Japanese company for its product Cod UNG. ArcticZymes AS, a leader in the development and commercialization of enzymes applied to molecular diagnostics, gene therapy, and protein purification, announces a new dual track supply agreement for its specialized enzyme, Cod UNG. ArticZymes’ Japanese …
Article: Decontamination of PCR master mixes can improve accuracy and sensitivity in microbiome analyses
A paper recently published in Letters in Applied Microbiology describes advantages of using ArcticZymes’ PCR Decontamination Kit in master mix clean-up prior to PCR in microbiome analysis applications. In molecular diagnostics and applied sciences, a current trend is to migrate from searching for a set of predefined microorganisms to identifying and quantifying all microorganisms present in the sample, known as …
ArcticZymes expands SAP and Cod UNG portfolio
ArcticZymes presents rSAP Glycerol-FREE and Cod UNG Triton-FREE. rSAP Glycerol-FREE becomes the fourth member of ArcticZymes’ glycerol-free product family, whereas the launch of Cod UNG Triton-FREE marks the first step towards maintaining a completely EU REACH compliant product portfolio after Triton X-100 becomes subject to authorisation in January 2021. Glycerol-free formulations enable efficient lyophilization. Lyophilization of enzyme products helps overcome …